Indraprastha Medical Corporation Limited (INDRAMEDCO) — Financial Results | 24 March 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Indraprastha Medical Corporation Limited announced closure of its trading window effective 1st April 2026 until 48 hours after the announcement of audited financial results for Q4 and FY2026. During this period, directors, designated employees, insiders, and their immediate relatives are prohibited from transacting in company securities under SEBI insider trading regulations.

📄 View Original Announcement (PDF)

About Indraprastha Medical Corporation Limited (INDRAMEDCO)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹3,279.6 Cr P/E: 17.4 ROE: 31.5% ROCE: 43.4% Div Yield: 1.12%

View full INDRAMEDCO stock details →

📡 Get AI alerts when INDRAMEDCO files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track INDRAMEDCO — Free

📊 More INDRAMEDCO filings

See all INDRAMEDCO filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when INDRAMEDCO files new disclosures

Track INDRAMEDCO filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track INDRAMEDCO — Free

Free account · 2 AI queries/day